Moreover, the up‐regulation of LINC00511 competitively sponges the miR‐124‐3p, thereby motivating the CCND2 and its encoded cyclin D2 protein expression, which might likely provide great promise for glioma therapeutics. The gene discussed is CCND2; the disease is glioma.